- ICPT has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $308.7 million.
- ICPT has traded 109,288 shares today.
- ICPT is down 3.3% today.
- ICPT was up 11.2% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ICPT with the Ticky from Trade-Ideas. See the FREE profile for ICPT NOW at Trade-Ideas More details on ICPT: Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid chemistry. ICPT has a PE ratio of 51.9. Currently there are 5 analysts that rate Intercept Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for Intercept Pharmaceuticals has been 550,700 shares per day over the past 30 days. Intercept has a market cap of $5.8 billion and is part of the health care sector and drugs industry. The stock has a beta of -3.22 and a short float of 9.9% with 0.77 days to cover. Shares are up 350.5% year-to-date as of the close of trading on Wednesday.